Waracharee Srifa

Waracharee Srifa

Auto-generated profile, based on publicly available information

Waracharee Srifa

Department of Pediatrics, Stanford University, Stanford, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2021 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
MCM. Kyle Cromer
M. Kyle Cromer
JCJoab Camarena
Joab Camarena
RMRenata M. Martin
Renata M. Martin
BLBenjamin J. Lesch
Benjamin J. Lesch
CVChristopher A. Vakulskas
Christopher A. Vakulskas
MPMatthew H. Porteus
Matthew H. Porteus

18 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
WSWaracharee Srifa
Waracharee Srifa
NKNina Kosaric
Nina Kosaric
AAAlvaro Amorin
Alvaro Amorin
OJOthmane Jadi
Othmane Jadi
YPYujin Park
Yujin Park
MPMatthew Porteus
Matthew Porteus
Human mesenchymal stromal cells (hMSCs) are a promising source for engineered cell-based therapies in which genetic engineering could enhance therapeutic efficacy and install novel cellular functions. Here, we describe an optimized Cas9-AAV6-based genome editing tool platform for site-specific mutagenesis and integration of up to more than 3 kilobases of exogenous DNA in the genome of hMSCs derived from the bone marrow, adipose tissue, and umbilical cord blood without altering their ex vivo characteristics. We generate safe harbor-integrated lines of engineered hMSCs and show that engineered luciferase-expressing hMSCs are transiently active in vivo in wound beds of db/db mice. Moreover, we generate PDGF-BB- and VEGFA-hypersecreting hMSC lines as short-term, local wound healing agents with superior therapeutic efficacy over wildtype hMSCs in the diabetic mouse model without replacing resident cells long-term. This study establishes a precise genetic engineering platform for genetic studies of hMSCs and development of engineered hMSC-based therapies.

13 July 2020 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
VWVolker Wiebking
Volker Wiebking
JPJames O. Patterson
James O. Patterson
RMRenata Martin
Renata Martin
MCMonica K. Chanda
Monica K. Chanda
CLCiaran M. Lee
Ciaran M. Lee
MPMatthew H. Porteus
Matthew H. Porteus

26 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MPMara Pavel-Dinu
Mara Pavel-Dinu
VWVolker Wiebking
Volker Wiebking
BDBeruh T. Dejene
Beruh T. Dejene
WSWaracharee Srifa
Waracharee Srifa
SMSruthi Mantri
Sruthi Mantri
MPMatthew H. Porteus
Matthew H. Porteus
The original version of this Article omitted the following from the Acknowledgements: “G.B. acknowledges the support from the Cancer Prevention and Research Institute of Texas (RR140081 and RR170721).”This has now been corrected in both the PDF and HTML versions of the Article.